← Back to headlines
Merck Splits Business to Separate Oncology from Non-Cancer Drugs
Merck is restructuring its business by separating its oncology division from non-cancer drug operations, a move reportedly in preparation for the 2028 patent expiry of its blockbuster cancer treatment, Keytruda.
23 Feb, 13:21 — 23 Feb, 13:21
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Daily wage increase for minimum wage earners in Davao Region
just now
Bureau of Customs Auctions More Discaya Luxury Vehicles for P25.7 Million
just now
President Mahama confident new Shama glass factory will be among Africa’s largest
6m ago
Demostat Launches 'Konzumer' Product Focused on Consumer Rights
6m ago